Researchers have identified a molecular target that could extend the [...]

BullFrog AI Holdings has entered a commercial agreement with a [...]

Levicept has reported Phase 2 clinical trial results for LEVI-04 [...]

Nuclera has launched a nanodisc panel designed to improve the [...]

The chief executive of Ribbon Biolabs has called for faster [...]

The US Food and Drug Administration (FDA) has reaffirmed that [...]

Tozorakimab has met its primary endpoint in two replicate Phase [...]

Senior figures from across industry, academia, investment and government have [...]

Researchers identify an IL-1β-driven inflammatory loop behind bone damage and [...]

FoRx Therapeutics presents preclinical data on FORX-428, a PARG inhibitor [...]